Examining the Efficacy of a Newly Developed Smoking Cessation Program
ESCaPe
Study of Newly Developed Program Designed to Create Greater Long-term Smoking Cessation Results.
1 other identifier
observational
15
1 country
1
Brief Summary
The goal of this clinical trial is to determine the success rate (efficacy) of a newly developed program to help smokers and vapers quit smoking. There will be no drugs of any nature involved, nor will there be any replacement addictions offered (ie; patches, gummies, etc.) It will also learn about the demographic profile of inbound participants. The main questions it aims to answer are: Does the new program offer an improved success rate for smoking cessation? Does the program eliminate the need for long term "trigger" management? Does the program effectively diminish the anxiety that is normally associated with smoking cessation? Participants will: Attend a 1 hour group zoom session each week for the duration of the program (8 weeks). Fill out an onboarding demographic questionnaire and exit demographic questionnaire. Agree to a 6 month follow up questionnaire regarding their continued success/failure. There are no physical meeting requirements. Participants can be located anywhere within the US.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedFirst Submitted
Initial submission to the registry
December 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2024
CompletedFirst Posted
Study publicly available on registry
December 24, 2024
CompletedDecember 24, 2024
December 1, 2024
2 months
December 18, 2024
December 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Initial Cessation
percentage of participants that report quitting smoking by the end of the program
8 weeks
Secondary Outcomes (2)
Extended Cessation
6 months
Permanent Cessation
1 year
Study Arms (1)
Session 1
Approximately 15-20 participants that have selected Session 1 as their preferred session
Interventions
Lifestyle modifications based on the Quit Center cessation program.
Eligibility Criteria
This study, although offered without geographical limitations, will be linited to United States residents
You may qualify if:
- must be addicted to nicotine either by cigarette or vaping
- must have access to an internet connected device, laptop, or smartphone
- must be 18 years old or older
You may not qualify if:
- currently enrolled in any weight-loss program
- currently enrolled in any behavioral modification program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Quit Center LLClead
Study Sites (1)
QuitCenter.org
Beaufort, North Carolina, 28516, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Richard Rubino
Quit Center LLC, Managing Member
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2024
First Posted
December 24, 2024
Study Start
October 28, 2024
Primary Completion
December 15, 2024
Study Completion
December 21, 2024
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be distributed. Aggregate data will be reported and will be available for other program's usage upon request to Quit Center LLC. Quit Center LLC reserves the right to limit the distribution of aggregate data.